Michinori Ogura Selected Research

Doxorubicin (Adriamycin)

5/2024	Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
1/2022	A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.
1/2021	A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial.
11/2018	Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
7/2016	Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
1/2013	Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705).
7/2012	Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508.
10/2011	Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial.
12/2010	Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305).
12/2010	Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michinori Ogura Research Topics

Disease

32	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 12/2002
26	Lymphoma (Lymphomas) 01/2021 - 03/2002
24	Neoplasms (Cancer) 01/2022 - 03/2002
19	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 03/2005
13	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 02/2003
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2022 - 03/2005
10	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 09/2010
8	Multiple Myeloma 06/2019 - 01/2008
8	Neutropenia 12/2017 - 01/2008
8	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2008
7	Disease Progression 05/2024 - 01/2008
7	Hodgkin Disease (Hodgkin's Disease) 04/2021 - 03/2005
7	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2021 - 03/2010
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2019 - 05/2013
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2021 - 06/2003
5	Infections 04/2019 - 10/2004
5	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2016 - 03/2010
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2019 - 11/2007
4	Exanthema (Rash) 03/2018 - 02/2009
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 09/2011
4	Febrile Neutropenia 12/2017 - 12/2009
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2017 - 10/2004
4	Anemia 01/2016 - 10/2006
4	Leukemia 02/2009 - 04/2002
3	Diarrhea 04/2019 - 10/2004
3	Rheumatoid Arthritis 11/2018 - 05/2017
3	Fatigue 03/2018 - 10/2006
3	Lymphopenia (Lymphocytopenia) 03/2018 - 03/2015
3	Pneumonia (Pneumonitis) 12/2017 - 11/2010
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2017 - 07/2012
3	Leukopenia 12/2016 - 11/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2014 - 02/2003
3	Breast Neoplasms (Breast Cancer) 01/2008 - 04/2002
2	Vomiting 04/2019 - 02/2012
2	Nausea 04/2019 - 12/2013
2	Hypoalbuminemia 03/2018 - 12/2017
2	Pleural Effusion (Pleural Effusions) 06/2017 - 02/2012
2	Hematologic Neoplasms (Hematological Malignancy) 05/2017 - 07/2015
2	Nasopharyngitis 01/2016 - 11/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 04/2014 - 06/2003
2	Colorectal Neoplasms (Colorectal Cancer) 08/2010 - 04/2002
2	Hypersensitivity (Allergy) 02/2009 - 03/2002
2	Lung Neoplasms (Lung Cancer) 10/2006 - 04/2002

Drug/Important Bio-Agent (IBA)

47	Rituximab (Mabthera)FDA Link 05/2024 - 03/2002
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 01/2008
12	Bendamustine Hydrochloride FDA Link 05/2022 - 09/2010
11	Vincristine (Oncovin)FDA LinkGeneric 05/2024 - 12/2010
10	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 12/2010
8	Prednisone (Sone)FDA LinkGeneric 05/2024 - 10/2011
8	Monoclonal AntibodiesIBA 06/2019 - 03/2002
6	CT-P10IBA 01/2022 - 05/2017
6	Biosimilar PharmaceuticalsIBA 01/2021 - 05/2017
6	Inotuzumab OzogamicinIBA 01/2018 - 08/2010
6	Cladribine FDA LinkGeneric 02/2011 - 02/2003
5	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 12/2010
5	AntibodiesIBA 01/2020 - 03/2002
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 02/2003
5	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2018 - 11/2007
5	Bortezomib (Velcade)FDA Link 01/2016 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2011
4	ofatumumab FDA Link 08/2017 - 05/2013
4	Imatinib Mesylate (Gleevec)FDA Link 06/2017 - 10/2004
4	Dexamethasone (Maxidex)FDA LinkGeneric 02/2017 - 01/2008
4	CalicheamicinsIBA 10/2016 - 05/2009
3	Brentuximab VedotinIBA 04/2021 - 07/2014
3	EnzymesIBA 04/2019 - 04/2002
3	Alanine Transaminase (SGPT)IBA 03/2018 - 10/2004
3	Dasatinib (BMS 354825)FDA Link 06/2017 - 02/2012
3	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 12/2009
3	mogamulizumabIBA 04/2014 - 03/2010
2	Antiviral Agents (Antivirals)IBA 01/2020 - 09/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 05/2005
2	Azacitidine (5 Azacytidine)FDA Link 12/2017 - 09/2011
2	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 01/2017
2	Lenalidomide (CC 5013)FDA Link 12/2016 - 03/2016
2	Etoposide (VP 16)FDA LinkGeneric 07/2016 - 01/2008
2	Vorinostat FDA Link 01/2016 - 06/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015 - 03/2015
2	CCR4 ReceptorsIBA 04/2014 - 03/2012
2	Immunoglobulin G (IgG)IBA 07/2013 - 02/2011
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2013 - 12/2010
2	Dacarbazine (DIC)FDA LinkGeneric 01/2013 - 12/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2013 - 12/2010
2	Anaplastic Lymphoma KinaseIBA 07/2012 - 06/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2012 - 08/2010
2	Sialic Acid Binding Ig-like Lectin 2IBA 05/2012 - 08/2010
2	purineIBA 02/2011 - 03/2005
2	Transaminases (Aminotransferases)IBA 11/2010 - 01/2008
2	fludarabineIBA 10/2009 - 11/2007

Therapy/Procedure

31	Therapeutics 11/2023 - 03/2002
29	Drug Therapy (Chemotherapy) 11/2023 - 03/2002
7	Stem Cell Transplantation 10/2020 - 03/2005
3	Hematopoietic Stem Cell Transplantation 06/2019 - 07/2013
3	Intravenous Infusions 08/2017 - 07/2009
3	Salvage Therapy 02/2017 - 06/2003
3	Radiotherapy 12/2014 - 03/2002
2	Induction Chemotherapy 10/2020 - 12/2009
2	Radioimmunotherapy 08/2016 - 01/2009
2	Transplantation 07/2013 - 01/2005